OpenVSafe by OpenVAERS
Search V-safe

YDV-42901-20743

4 vaccinations 2 coded responses 11 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
480 / MI
Registered
2021-10-27
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-30
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-20
    Dose 2 — Pfizer-BioNTech
  3. 2021-08-19
    Dose 3 — Pfizer-BioNTech
  4. 2021-10-27
    Registered in v-safe
  5. 2021-11-18
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  6. 2022-02-17
    Survey response — 6 months, dose 3
    MedDRA: Postpartum state, Pre-eclampsia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Postpartum preeclampsia
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-02-17
    Report sent to call center — 6 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · 1 call case(s)
  8. 2022-02-23
  9. 2022-02-28
  10. 2022-08-19
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in
  11. 2022-09-27
    Dose 4 — Pfizer-BioNTech
    Co-administered: Flu
  12. 2022-09-28
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness
    Adult check-in
  13. 2022-09-29
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  14. 2022-09-30
    Survey response — days 1–6 daily, dose 4
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Swollen lumpy node in armpit
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-10-01
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  16. 2022-10-02
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  17. 2022-10-03
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  18. 2022-12-27
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  19. 2023-03-28
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-30Pfizer-BioNTech No
22021-02-20Pfizer-BioNTech No
32021-08-19Pfizer-BioNTech No
42022-09-27Pfizer-BioNTech Flu

Call center

ReportedOutcomeVAERS-related outcome
2022-02-17 Unsuccessful

Free text

Release 11 — 6 months, dose 3

2022-02-17

Symptoms: Postpartum preeclampsia

Release 12 — days 1–6 daily, dose 4

2022-09-30

Systemic reaction (other): Swollen lumpy node in armpit

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDPostpartum state · · ✓
SDPre-eclampsia · · ✓
SROLymphadenopathy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…